For the year ending 2025-12-31, LRMR has $145,842K in assets. $67,757K in debts. $85,412K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 85,412 | |||
| Short-term marketable securities | 51,440 | |||
| Prepaid expenses and other current assets | 5,170 | |||
| Total current assets | 142,022 | |||
| Total fixed assets | 2,515 | |||
| Less accumulated depreciation | 1,893 | |||
| Property and equipment, net | 622 | |||
| Operating lease right-of-use assets | 2,069 | |||
| Restricted cash | 606 | |||
| Other assets | 523 | |||
| Total assets | 145,842 | |||
| Accounts payable | 5,216 | |||
| Accrued expenses | 58,474 | |||
| Operating lease liabilities, current | 1,105 | |||
| Total current liabilities | 64,795 | |||
| Operating lease liabilities | 2,962 | |||
| Total liabilities | 67,757 | |||
| Common stock, 0.001 par value per share 115,000,000 shares authorized as of december 31, 2025 and december 31, 2024 83,090,392 and 63,815,065 shares issued and outstanding as of december 31, 2025 and december 31, 2024, respectively | 83 | |||
| Additional paid-in capital | 512,779 | |||
| Accumulated deficit | -434,831 | |||
| Accumulated other comprehensive gain | 54 | |||
| Total stockholders' equity | 78,085 | |||
| Total liabilities and stockholders' equity | 145,842 | |||
Larimar Therapeutics, Inc. (LRMR)
Larimar Therapeutics, Inc. (LRMR)